Perkins Discovery holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Perkins Discovery Fund PDFDX
- NAV / 1-Day Return 52.98 / −1.38 %
- Total Assets 6.8M
-
Adj. Expense Ratio
2.500%
- Expense Ratio 2.560%
- Distribution Fee Level High
- Share Class Type No Load
- Category Health
- Investment Style Small Growth
- Min. Initial Investment 2,500
- Status Closed
- TTM Yield 4.98%
- Turnover 10%
USD | NAV as of Jun 06, 2026 | 1-Day Return as of Jun 06, 2026, 1:30 AM GMT+0
Morningstar’s Analysis PDFDX
Will PDFDX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the PDFDX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of PDFDX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 68.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Axogen Inc | 11.43 | 662,600 | Healthcare |
Natera Inc | 11.21 | 649,968 | Healthcare |
Veracyte Inc | 7.78 | 450,940 | Healthcare |
ANI Pharmaceuticals Inc | 7.63 | 442,175 | Healthcare |
SkyWater Technology Inc | 6.86 | 397,445 | Technology |
ePlus Inc | 6.49 | 376,250 | Technology |
Digi International Inc | 4.99 | 289,200 | Technology |
Butterfly Network Inc Ordinary Shares - Class A | 4.22 | 244,420 | Healthcare |
BioLife Solutions Inc | 4.11 | 238,500 | Healthcare |
Magnite Inc | 4.10 | 237,600 | Communication Services |
United States